Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
LEGN
#6990
Legend Biotech Corporation American Depositary Shares
19.000
0
-0.39%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.39%
Variazione Mensile
+4.17%
Variazione di 6 mesi
-40.59%
Variazione Annuale
-40.59%
Chiusura Precedente
19.075
0
Open
18.990
0
Bid
Ask
Low
18.990
0
High
19.000
0
Volume
131
Mercati
Mercato Azionario Statunitense
Salute
LEGN
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
367.3 M
1.37 B
Valuation ratios
Enterprise value
11.95 B
63.91 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Notizie
These Stocks Lead Dow Jones In February. Hint: It's Not AI Companies.
What Gilead Is Getting Through The Acquisition Of Arcellx
American Express, Oracle among market cap stock movers on Monday
Raymond James conferma il rating su Legend Biotech per il gap di valutazione
Raymond James reiterates Legend Biotech stock rating on valuation gap
Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J
Germany stocks lower at close of trade; DAX down 1.03%
Germany stocks higher at close of trade; DAX up 1.16%
Il rating delle azioni Legend Biotech declassato da Rothschild Redburn per timori sulla concorrenza
Legend Biotech stock rating downgraded by Rothschild Redburn on competition concerns
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Il titolo di Legend Biotech tocca il minimo di 52 settimane a $18,07